Special Issue "Novel Design and Synthesis of Anticancer Agents"
Deadline for manuscript submissions: closed (31 May 2023) | Viewed by 30430
Neoplastic diseases and cardiovascular diseases are the leading causes of premature death. Despite the significant progress made over the last few decades in the molecular basis of the carcinogenesis process, as well as diagnostic and prophylactic processes, the treatment currently used for neoplastic diseases is still not very specific and effective. We are currently facing numerous challenges related to the search for progress in cancer chemotherapy.
The design and synthesis of more effective and more selective novel anticancer drug candidates with promising activity and minimal side effects is still a current problem.
Currently, the search for new anticancer therapies is focused, inter alia, on the search for improved pharmaceutical forms (drug forms) and new analogues of the currently used anticancer drugs, on the study of the antitumor activity of drugs currently used for other indications, and on the study of new chemical compounds of natural or synthetic origin with the anticancer activities.
In this Special Issue, we focus on research related to the design and synthesis of new substances with potential anticancer activity, as well as the study of the mechanisms of this action. I cordially invite researchers working in this field to contribute original research articles and review articles.
Dr. Małgorzata Jeleń
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- anti-proliferative activity
- anticancer activity
- cancer cell lines
- mechanism of anticancer action
- drug discovery
- drug design